The total duration of this study for each participant is approximately 28 weeks, which includes a screening period of 4 weeks, followed by a 24-week double blind placebo-controlled treatment period. At the end of the treatment period, all participants will have the option to enter a separate study, the blinded extension study
Articles
October 29, 2024
Tufts Medicine’s stroke experts share what you need to know about stroke symptoms, signs, treatment and recovery.